| Validation of the disease risk index for outcome of patients undergoing allogeneic hematopoietic stem cell transplantation after T cell depletion | Biology of blood and marrow transplantation |  | | 2014 | 626 | 1 |
|
| Leucémie lymphoïde chronique : quand débuter le traitement ? | Revue médicale suisse | | | 2013 | 664 | 1 |
|
| Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT | Bone marrow transplantation |  | | 2012 | 800 | 0 |
|
| Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients | Haematologica |  | | 2011 | 1,058 | 683 |
|
| Invasive microsporidiosis in allogeneic haematopoietic SCT recipients | Bone marrow transplantation | | | 2010 | 577 | 0 |
|
| Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors | Blood | | | 2003 | 342 | 220 |
|
| Expression of transcription factors Pu.1, Spi-B, Blimp-1, BSAP and oct-2 in normal human plasma cells and in multiple myeloma cells | British journal of haematology | | | 2002 | 165 | 486 |
|
| Acquired and transient RBC CD55 deficiency (Inab phenotype) and anti-IFC | Transfusion | | | 2002 | 272 | 0 |
|
